Biotechnology, Latest News, Newsroom Sep 23rd Pfizer is nearly ready to resume dosing in its phase 3 hemophilia A gene therapy trial.
Biotechnology, Latest News, Newsroom Sep 14th Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine
